Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Supply, Demand and Key Producers, 2023-2029

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Supply, Demand and Key Producers, 2023-2029

The global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Porcine viral diarrhea is a common and frequently-occurring disease in pigs, and the most serious pathogens are porcine transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV) and porcine rotavirus (PoRV). All three pathogens can infect pigs of all ages and can cause symptoms such as vomiting, watery diarrhea and dehydration. The harm to piglets within 10 days of age is particularly serious, and the morbidity and mortality are high, up to 100%. The vaccine is inoculated at the Houhai point, and it is safe and effective for all pigs including suckling piglets and pregnant sows. It realizes the prevention of three diseases with one shot, reduces the immune stress of pigs, and reduces the labor intensity and breeding of vaccination. cost, and has a significant effect on the prevention of single infection or mixed infection of the three pathogens.

This report studies the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine total production and demand, 2018-2029, (K Doses)

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine total production value, 2018-2029, (USD Million)

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine consumption by region & country, CAGR, 2018-2029 & (K Doses)

U.S. VS China: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine domestic production, consumption, key domestic manufacturers and share

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Doses)

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Doses)

This reports profiles key players in the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Santé Animale, MSD Animal Health, SPAH, Nanjing Tianbang Biological Technology, Sichuan Huapai Bio-pharmaceutical and Guangdong Winsun Bio Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market, Segmentation by Type
Live Vaccine
Inactivated Vaccine

Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market, Segmentation by Application
Piglets
Adults Pigs

Companies Profiled:
Zoetis Animal Health
Boehringer-Ingelheim
Merck Animal Health
Ceva Santé Animale
MSD Animal Health
SPAH
Nanjing Tianbang Biological Technology
Sichuan Huapai Bio-pharmaceutical
Guangdong Winsun Bio Pharmaceutical
Wuhan Keqian Biology
Shanghai Hile Bio-Technology
Harbin Pharmaceutical Group Bio-Vaccine
Ringpu
Shandong Huahong Bioengineering
Weike Biotechnology
Nanjing Tianbang Biological Technology
China Animal Husbandry Industry

Key Questions Answered

1. How big is the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?

2. What is the demand of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?

3. What is the year over year growth of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?

4. What is the production and production value of the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?

5. Who are the key producers in the global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market?

6. What are the growth factors driving the market demand?